Singapore

ANTIBODIES is the buzzword in the race to cure cancer. Naturally produced by our immune systems, they can be used as drugs to bind to target proteins and invoke certain effects, such as destroying cancer cells.

But the industry bottleneck is that once researchers identify a good target protein, it is difficult to find the right antibodies to act against it.